BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/26/2018 11:38:21 AM | Browse: 1267 | Download: 2956
 |
Received |
|
2018-07-01 13:16 |
 |
Peer-Review Started |
|
2018-07-02 11:37 |
 |
First Decision by Editorial Office Director |
|
2018-07-24 17:03 |
 |
Return for Revision |
|
2018-07-25 03:26 |
 |
Revised |
|
2018-08-16 13:51 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2018-09-04 08:06 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2018-10-05 23:25 |
 |
Articles in Press |
|
2018-10-05 23:25 |
 |
Edit the Manuscript by Language Editor |
|
2018-10-15 00:59 |
 |
Typeset the Manuscript |
|
2018-10-22 07:28 |
 |
Publish the Manuscript Online |
|
2018-10-26 11:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ya-Wen Zhang, Wei-Ling Hu, Yuan Cai, Wen-Fang Zheng, Qin Du, John J Kim, John Y Kao, Ning Dai and Jian-Min Si |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| the Zhejiang Science and Technology Project |
LGF18H160012 |
|
| Corresponding Author |
Wei-Ling Hu, MD, PhD, Doctor, Doctor, Department of Gastroenterology, Sir Run Run Shaw Hospital, School of Medicine, Institute of Gastroenterology, Zhejiang University, No. 3 East Qingchun Road, Hangzhou 310016, Zhejiang Province, China. huweiling@zju.edu.cn |
| Key Words |
Helicobacter pylori; Furazolidone; Quadruple regimen; Side effects; Eradication |
| Core Tip |
This study examined the outcomes of furazolidone- and amoxicillin-based quadruple therapy as both primary and rescue therapies for Helicobacter pylori (H. pylori) infection in nearly a thousand patients. Detailed data on adverse events and factors associated with failed H. pylori eradication were evaluated. Furazolidone- and amoxicillin-based quadruple therapy demonstrated a high H. pylori eradication rate exceeding 90% with a favorable safety profile in a real-world setting. Abstinence from alcohol during therapy and strict medication adherence may further optimize eradication. The results validate updated guidelines recommending furazolidone-based quadruple therapy as a first-line treatment for H. pylori infection in areas with a high prevalence of clarithromycin resistance. |
| Publish Date |
2018-10-26 11:38 |
| Citation |
Zhang YW, Hu WL, Cai Y, Zheng WF, Du Q, Kim JJ, Kao YJ, Dai N, Si JM. Outcomes of furazolidone- and amoxicillin-based quadruple therapy for Helicobacter pylori infection and predictors of failed eradication. World J Gastroenterol 2018; 24(40): 4596-4605 |
| URL |
http://www.wjgnet.com/1007-9327/full/v24/i40/4596.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v24.i40.4596 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.